TY - JOUR
T1 - HR-pQCT Measures of Bone Microarchitecture Predict Fracture
T2 - Systematic Review and Meta-Analysis
AU - Mikolajewicz, Nicholas
AU - Bishop, Nick
AU - Burghardt, Andrew J.
AU - Folkestad, Lars
AU - Hall, Anthony
AU - Kozloff, Kenneth M.
AU - Lukey, Pauline T.
AU - Molloy-Bland, Michael
AU - Morin, Suzanne N.
AU - Offiah, Amaka C.
AU - Shapiro, Jay
AU - van Rietbergen, Bert
AU - Wager, Kim
AU - Willie, Bettina M.
AU - Komarova, Svetlana V.
AU - Glorieux, Francis H.
N1 - Funding Information:
This study was supported by the Mereo BioPharma Group. Authors' roles: Conceptualization: AH. Methodology: KW, MMB, NM, SVK, and AH. Data collection: MMB, KW, and NM. Formal analysis: MMB, KW, NM, and SVK. Interpretation: NM, NB, AJB, LF, AH, KMK, PTL, ACO, JS, BvR, SNM, BMW, SVK, FHG, and DL. Manuscript preparation: MMB, KW, NM, and SVK. All authors contributed to the critical revision and approval of the final manuscript. A
Funding Information:
ACO has received grant funding from Alexion and honoraria from Alexion, BioMarin, and Infomed. AJB has received institutional research support from Ultragenyx. BMW is a consultant for Mereo BioPharma and has received research grants from Mereo BioPharma. BvR is a consultant for Scanco Medical AG. FHG is a consultant to Amgen, Mereo BioPharma, and Novartis, and has received research grants from Amgen and Mereo BioPharma. KMK has received institutional research support and materials from Mereo BioPharma, research materials from Amgen and UCB Pharma, and institutional research support from Cayman Chemical for unrelated studies. KW is an employee of Oxford PharmaGenesis, which received funding to conduct this systematic review, and for medical writing support, from Mereo Biopharma. MMB is an independent contractor for Oxford PharmaGenesis, which received funding to conduct this systematic review, and for medical writing support, from Mereo Biopharma. NB has received grant funding from Alexion, Amgen, and Biomarin, honoraria from Alexion, Kyowa Kirin, and Mereo BioPharma, and is a consultant for Mereo BioPharma and UCB. PTL is an independent consultant to various biotech and academics, including Mereo BioPharma. SNM has received research grants paid to the research institution by Amgen and Merck.
Publisher Copyright:
© 2019 American Society for Bone and Mineral Research
PY - 2020/3
Y1 - 2020/3
N2 - High-resolution peripheral quantitative computed tomography (HR-pQCT) is a noninvasive imaging modality for assessing volumetric bone mineral density (vBMD) and microarchitecture of cancellous and cortical bone. The objective was to (1) assess fracture-associated differences in HR-pQCT bone parameters; and (2) to determine if HR-pQCT is sufficiently precise to reliably detect these differences in individuals. We systematically identified 40 studies that used HR-pQCT (39/40 used XtremeCT scanners) to assess 1291 to 3253 and 3389 to 10,687 individuals with and without fractures, respectively, ranging in age from 10.9 to 84.7 years with no comorbid conditions. Parameters describing radial and tibial bone density, microarchitecture, and strength were extracted and percentage differences between fracture and control subjects were estimated using a random effects meta-analysis. An additional meta-analysis of short-term in vivo reproducibility of bone parameters assessed by XtremeCT was conducted to determine whether fracture-associated differences exceeded the least significant change (LSC) required to discern measured differences from precision error. Radial and tibial HR-pQCT parameters, including failure load, were significantly altered in fracture subjects, with differences ranging from -2.6% (95% confidence interval [CI] -3.4 to -1.9) in radial cortical vBMD to -12.6% (95% CI -15.0 to -10.3) in radial trabecular vBMD. Fracture-associated differences reported by prospective studies were consistent with those from retrospective studies, indicating that HR-pQCT can predict incident fracture. Assessment of study quality, heterogeneity, and publication biases verified the validity of these findings. Finally, we demonstrated that fracture-associated deficits in total and trabecular vBMD and certain tibial cortical parameters can be reliably discerned from HR-pQCT-related precision error and can be used to detect fracture-associated differences in individual patients. Although differences in other HR-pQCT measures, including failure load, were significantly associated with fracture, improved reproducibility is needed to ensure reliable individual cross-sectional screening and longitudinal monitoring. In conclusion, our study supports the use of HR-pQCT in clinical fracture prediction. (c) 2019 American Society for Bone and Mineral Research.
AB - High-resolution peripheral quantitative computed tomography (HR-pQCT) is a noninvasive imaging modality for assessing volumetric bone mineral density (vBMD) and microarchitecture of cancellous and cortical bone. The objective was to (1) assess fracture-associated differences in HR-pQCT bone parameters; and (2) to determine if HR-pQCT is sufficiently precise to reliably detect these differences in individuals. We systematically identified 40 studies that used HR-pQCT (39/40 used XtremeCT scanners) to assess 1291 to 3253 and 3389 to 10,687 individuals with and without fractures, respectively, ranging in age from 10.9 to 84.7 years with no comorbid conditions. Parameters describing radial and tibial bone density, microarchitecture, and strength were extracted and percentage differences between fracture and control subjects were estimated using a random effects meta-analysis. An additional meta-analysis of short-term in vivo reproducibility of bone parameters assessed by XtremeCT was conducted to determine whether fracture-associated differences exceeded the least significant change (LSC) required to discern measured differences from precision error. Radial and tibial HR-pQCT parameters, including failure load, were significantly altered in fracture subjects, with differences ranging from -2.6% (95% confidence interval [CI] -3.4 to -1.9) in radial cortical vBMD to -12.6% (95% CI -15.0 to -10.3) in radial trabecular vBMD. Fracture-associated differences reported by prospective studies were consistent with those from retrospective studies, indicating that HR-pQCT can predict incident fracture. Assessment of study quality, heterogeneity, and publication biases verified the validity of these findings. Finally, we demonstrated that fracture-associated deficits in total and trabecular vBMD and certain tibial cortical parameters can be reliably discerned from HR-pQCT-related precision error and can be used to detect fracture-associated differences in individual patients. Although differences in other HR-pQCT measures, including failure load, were significantly associated with fracture, improved reproducibility is needed to ensure reliable individual cross-sectional screening and longitudinal monitoring. In conclusion, our study supports the use of HR-pQCT in clinical fracture prediction. (c) 2019 American Society for Bone and Mineral Research.
KW - ANALYSIS
KW - QUANTITATION OF BONE
KW - BONE QCT
KW - CLINICAL TRIALS
KW - FRACTURE RISK ASSESSMENT
KW - STATISTICAL METHODS
KW - QUANTITATIVE COMPUTED-TOMOGRAPHY
KW - DISTAL RADIUS
KW - POSTMENOPAUSAL WOMEN
KW - CORTICAL POROSITY
KW - PRECISION ERROR
KW - DENSITY
KW - TIBIA
KW - MICROSTRUCTURE
KW - REPRODUCIBILITY
KW - FOREARM
U2 - 10.1002/jbmr.3901
DO - 10.1002/jbmr.3901
M3 - (Systematic) Review article
C2 - 31643098
SN - 0884-0431
VL - 35
SP - 446
EP - 459
JO - Journal of Bone and Mineral Research
JF - Journal of Bone and Mineral Research
IS - 3
ER -